Skip to main content

Table 2 Frequencies of serotypes and antibiotic resistance rates found among 1590 isolates of Streptococcus pneumoniae among Aboriginal people in Western Australia, August 2008–November 2014. PCV13 was introduced on July 1 2011

From: Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population

 

Isolates

penI (%)

penR (%)

cotrR (%)

eryR (%)

tetR (%)

Serotype

Pre (n)

Post (n)

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Pre

Post

16F

62

48

32.3

25.0

0.0

0.0

0.0

0.0

8.1

0.0

6.5

0.0

6C

73

30

0.0

0.0

0.0

0.0

64.4

43.3

4.1

3.3

0.0

0.0

11A

40

56

7.5

10.7

0.0

0.0

17.5

26.8

2.5

0.0

0.0

0.0

19F

41

45

90.2

75.6

0.0

4.4

0.0

4.4

0.0

6.7

0.0

4.4

19A

58

25

39.7

52.0

5.2

8.0

43.1

56.0

10.3

24.0

25.9

44.0

15B

27

49

14.8

2.0

0.0

0.0

7.4

18.4

11.1

8.2

0.0

0.0

23F

43

18

4.7

0.0

0.0

0.0

81.4

100.0

81.4

100.0

76.7

94.4

6A

37

18

2.7

0.0

0.0

0.0

8.1

11.1

59.5

50.0

2.7

0.0

10A

26

28

3.8

0.0

0.0

0.0

61.5

35.7

0.0

0.0

0.0

0.0

23B

32

18

18.8

38.9

0.0

0.0

0.0

11.1

0.0

0.0

0.0

0.0

15C

16

27

6.3

3.7

0.0

0.0

25.0

18.5

0.0

7.4

0.0

0.0

34

23

14

0.0

0.0

0.0

0.0

0.0

0.0

0.0

7.1

0.0

0.0

22F

21

16

0.0

0.0

0.0

0.0

0.0

0.0

71.4

50.0

0.0

0.0

35B

15

19

13.3

15.8

0.0

0.0

6.7

0.0

0.0

10.5

0.0

0.0

3

17

13

0.0

7.7

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

33F

21

9

4.8

0.0

0.0

0.0

4.8

11.1

0.0

22.2

0.0

11.1

7C

12

17

0.0

0.0

0.0

0.0

0.0

0.0

16.7

70.6

0.0

0.0

21

8

20

0.0

0.0

0.0

0.0

37.5

10.0

0.0

5.0

0.0

0.0

23A

13

15

0.0

6.7

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

38

10

18

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

22.2

15A

6

19

50.0

73.7

0.0

0.0

33.3

31.6

83.3

73.7

50.0

73.7

22A

14

7

7.1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

31

12

12

0.0

0.0

0.0

0.0

0.0

0.0

16.7

0.0

0.0

0.0

17F

9

10

11.1

0.0

0.0

0.0

0.0

0.0

55.6

10.0

0.0

0.0

9 N

8

10

0.0

0.0

0.0

0.0

0.0

0.0

75.0

40.0

75.0

50.0

35F

10

8

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

8

6

11

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

7F

12

4

0.0

0.0

0.0

0.0

0.0

0.0

8.3

0.0

0.0

0.0

18A

7

9

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

7B

0

15

0.0

100.0

0.0

0.0

0.0

100.0

0.0

100.0

0.0

93.3

9 V

11

4

100.0

100.0

0.0

0.0

100.0

100.0

0.0

25.0

0.0

0.0

1

7

4

14.3

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

29

1

10

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

12F

7

3

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

10F

5

1

0.0

0.0

0.0

0.0

100.0

100.0

0.0

0.0

0.0

0.0

4

5

0

20.0

0.0

0.0

0.0

20.0

0.0

0.0

0.0

0.0

0.0

18C

3

2

0.0

0.0

0.0

0.0

100.0

100.0

0.0

0.0

0.0

0.0

13

1

3

0.0

33.3

0.0

0.0

0.0

0.0

0.0

33.3

0.0

0.0

20

2

2

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

33B

4

0

50.0

0.0

0.0

0.0

0.0

0.0

50.0

0.0

0.0

0.0

6B

3

0

0.0

0.0

0.0

0.0

0.0

0.0

33.3

0.0

0.0

0.0

33D

2

1

100.0

100.0

0.0

0.0

0.0

0.0

100.0

100.0

0.0

0.0

9A

1

0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

11C

0

1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

14

0

1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

100.0

0.0

0.0

24F

0

1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

25B

0

1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

37

1

0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

NT

126

90

76.2

63.3

0.0

0.0

46.0

38.9

34.1

23.3

9.5

11.1

TOTAL

858

732

25.5

23.4

0.3

0.5

26.1

21.3*

18.5

17.5

8.6

10.7

  1. 48 serotypes were identified among 1374 serotypeable isolates, 216 isolates were non-serotypeable (NT)
  2. Cotr cotrimoxazole, ery erythromycin, tet tetracycline, pen penicillin; R resistant, I intermediate resistance
  3. *p < 0.05